Myeloablative Therapy Prevails in AML Transplant Study

]]>(MedPage Today) -- ORLANDO--Myeloablative conditioning (MAC) led to a long-term survival benefit versus reduced-intensity conditioning (RIC) for patients with acute myeloid leukemia (AML) treated with hematopoietic cell transplantation, updated...